There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy ...

Timely PEP with antivirals such as oral oseltamivir (Tamiflu) protects household contacts in influenza cases, he noted, but ...

Novo Nordisk submitted a BLA to the Food and Drug Administration for denecimig for the treatment of hemophilia A in September 2025.

Botulinum toxin may slightly reduce monthly migraine days but has higher discontinuation rates due to adverse events.

A Public Health Alerts report today details successful administration of intramuscular immunoglobulin (IMIG) as post-exposure ...

A US study found that giving oseltamivir to ≥ 70% of nursing home residents within 48 hours of an outbreak cut ...

Data show many patients discontinue or switch treatment within the first year ...

The efficacy of continuous antibiotic prophylaxis in preventing urinary tract infection (UTI) in infants with grade III, IV, or V vesicoureteral reflux is controversial. In this investigator-initiated ...

DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep vein ...

Emicizumab (ACE910) bridges activated factor IX and factor X to restore the function of activated factor VIII, which is deficient in persons with hemophilia A. This phase 3, multicenter trial assessed ...